NEW YORK (Reuters Health) – In patients being treated for acute coronary syndromes (ACS), the loading dose of ticagrelor has a stronger inhibitory effect on platelets than does…
NEW YORK (Reuters Health) – Percutaneous revascularization of the left main coronary artery can be performed via the transradial approach, with success rates similar to transfemoral access, according…
NEW YORK (Reuters Health) – In terms of efficacy and safety, low-molecular weight heparin is better than unfractionated heparin in the treatment of patients presenting with cerebral venous…
NEW YORK (Reuters Health) – Among patients undergoing left atrial radiofrequency catheter ablation for treatment of paroxysmal or persistent atrial fibrillation, the risk of symptomatic cerebral thromboembolism is…
NEW YORK (Reuters Health) – Patients with atrial fibrillation undergoing pulmonary vein isolation by radiofrequency catheter ablation are less likely to have immediate recurrence of AF if they’re…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that anticoagulation may not need to be interrupted in patients undergoing elective coronary angiography. However, the quality of…
NEW YORK (Reuters Health) – For octogenarians undergoing percutaneous coronary intervention, the use of drug-eluting stents is safe and more effective than using bare metal stents, a Dutch…
NEW YORK (Reuters Health) – The GLP-1 receptor agonist exenatide used to treat type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) events, compared…
NEW YORK (Reuters Health) – For patients with significant carotid artery stenosis, undergoing carotid artery stenting (CAS) carries a higher risk of death or stroke than does carotid…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the steps needed to reduce the incidence of catheter related blood stream infection (CRBSI).…